Yildiz; Cafer
Patent Applications and Registrations
Patent applications and USPTO patent grants for Yildiz; Cafer.The latest application filed is for "monoclonal antibodies against the active site of factor xi and uses thereof".
- Yildiz; Cafer - Arnhem NL
| Patent | Date |
|---|---|
| Monoclonal antibodies against the active site of factor XI and uses thereof Grant 11,059,905 - Boross , et al. July 13, 2 | 2021-07-13 |
| Binding molecules that bind human complement factor C2 and uses thereof Grant 10,717,785 - Hack , et al. | 2020-07-21 |
| Monoclonal antibodies against the active site of factor XI and uses thereof App 20190106509 - Boross; Peter ; et al. | 2019-04-11 |
| Binding Molecules That Bind Human Complement Factor C2 And Uses Thereof App 20180319895 - Hack; Cornelis Erik ; et al. | 2018-11-08 |
| Binding molecules that bind human complement factor C2 and uses thereof Grant 9,944,717 - Hack , et al. April 17, 2 | 2018-04-17 |
| Binding Molecules That Bind Human Complement Factor C2 And Uses Thereof App 20160108134 - HACK; CORNELIS ERIK ; et al. | 2016-04-21 |
| Compounds For Use In Boosting Coagulation App 20140356377 - Hack; Cornelis Erik ; et al. | 2014-12-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 